Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,017-2,028 of 4,306
Drug study icon
CompletedNCT00294008

Treatment Adherence for schizophrenia

This study is completed. It is testing treatment Adherence for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
Sponsor
Janssen Korea, Ltd., Korea
Condition
Schizophrenia
Drug study icon
CompletedNCT01829048

Safety study of PF-02545920 in schizophrenia

This study is completed in the United States. It is testing PF-02545920 for schizophrenia.

In Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Pfizer
Condition
Schizophrenia
Drug study icon
CompletedNCT01518894

Safety study of PF-04958242 in schizophrenia

This study is completed in the United States. It is testing PF-04958242 for schizophrenia.

In Long Beach
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Biogen
Condition
Schizophrenia
Drug study icon
CompletedNCT02281773

Four Different Doses of BI 409306 Compared to Placebo Given for schizophrenia

This study is completed in the United States, in Canada, in Germany, .... It is testing Four Different Doses of BI 409306 Compared to Placebo Given for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Canada, Germany, ...
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
Drug study icon
CompletedNCT06225115

Safety study of KYN-5356 in Schizophrenia

This study is completed in the United States. It is testing KYN-5356 for Schizophrenia.

In Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Kynexis B.V.
Condition
Schizophrenia
Other study type icon
CompletedNCT01394601

A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Chita
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Russia
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT03809325

A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly

This study is completed in France, in the United Kingdom, in Belgium, .... It focuses on Schizophrenia.

Multiple locations, including Brussels
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
France, United Kingdom, Belgium, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.